The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical evaluations favor interpretable approaches such as Bayesian and logistic models, while feature-weighted gradient boosting incorporates molecular diagnostic inputs [277].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [277]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Analyzing Learned Molecular Representations for Property Prediction
Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00237 · Cited by 1,923
Sarker, I. H. (2022) · SN Computer Science · doi:10.1007/s42979-022-01043-x · Cited by 1,208
Collignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
de Hond, A. A. H., Leeuwenberg, A. M., Hooft, L., Kant, I. M. J., Nijman, S. W. J., van Os, H. J. A., Aardoom, J. J., Debray, T. P. A., Schuit, E., van Smeden, M., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-021-00549-7 · Cited by 499
Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397
AI-Driven Clinical Decision Support Systems: An Ongoing Pursuit of Potential
Elhaddad, M., & Hamam, S. (2024) · Cureus · doi:10.7759/cureus.57728 · Cited by 301
Discovering highly potent antimicrobial peptides with deep generative model HydrAMP
Szymczak, P., Możejko, M., Grzegorzek, T., Jurczak, R., Bauer, M., Neubauer, D., Sikora, K., Michalski, M., Sroka, J., Setny, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36994-z · Cited by 231
Research works printed but not linked: 169
- 10.1016/S2214-109X(21)00163-7 · doi:10.1016/s2214-109x(21)00163-7
- Lamba V. and Dhanireddy R.: Antimicrobial associated harm and the role for effective antimicrobial stewardship. This Inaug Issue JAAPI Is Dedic Legend Indian Physicians 2021; 1: 76.
- Ajulo S. and Awosile B.: Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. Plos One 2024; 19: e0297921. · DOI · Paper page
- Theuretzbacher U., Baraldi E., Ciabuschi F. and Callegari S.: Challenges and shortcomings of antibacterial discovery projects. Clin Microbiol Infect 2023; 29: 610. · DOI
- 10.1097/QCO.0000000000000406 · DOI
- 10.1016/j.heliyon.2024.e26888 · DOI · Paper page
- 10.1093/infdis/jiae348 · DOI
- de la Lastra J.M.P., Wardell S.J., Pal T., de la Fuente-Nunez C. and Pletzer D.: From Data to Decisions: Leveraging Artificial Intelligence and Machine Learning in Combating Antimicrobial Resistance–a Comprehensive Review. J Med Syst 2024; 48: 71. · DOI
- Shaik S., Singh A., Suresh A. and Ahmed N.: Genome informatics and machine learning-based identification of antimicrobial resistance-encoding features and virulence attributes in escherichia coli genomes representing globally prevalent lineages, including high-risk clonal complexes. mBio 2022; 13. e03796-03721. · DOI
- Zhang C., Ju Y., Tang N., Li Y., Zhang G., Song Y., Fang H., Yang L. and Feng J.: Systematic analysis of supervised machine learning as an effective approach to predicate β-lactam resistance phenotype in Streptococcus pneumoniae. Brief Bioinforma 2019; 21: 1347. · DOI
- 10.1038/s41579-023-00984-1 · DOI · Paper page
- Fenske G.J. and Scaria J.: Analysis of 56,348 genomes identifies the relationship between antibiotic and metal resistance and the spread of multidrug-resistant non-typhoidal salmonella. Microorganisms 2021; 9: 1468. · doi:10.3390/microorganisms9071468
- Weaver D.T., King E.S., Maltas J. and Scott J.G.: Reinforcement learning informs optimal treatment strategies to limit antibiotic resistance. Proc Natl Acad Sci USA 2024; 121: e2303165121. · DOI
- Wang Y., Liu A., Yang J., Wang L., Xiong N., Cheng Y. and Wu Q.: Clinical knowledge-guided deep reinforcement learning for sepsis antibiotic dosing recommendations. Artif Intell Med 2024; 150: 102811. · DOI
- Popa S.L., Pop C., Dita M.O., Brata V.D., Bolchis R., Czako Z., Saadani M.M., Ismaiel A., Dumitrascu D.I., Grad S., David L., Cismaru G. and Padureanu A.M.: Deep Learning and Antibiotic Resistance. Antibiotics 2022; 11: 1674. · DOI
- Karp B.E., Tate H., Plumblee J.R., Dessai U., Whichard J.M., Thacker E.L., Hale K.R., Wilson W., Friedman C.R. and Griffin P.M.: National antimicrobial resistance monitoring system: two decades of advancing public health through integrated surveillance of antimicrobial resistance. Foodborne Pathog Dis 2017; 14: 545. · DOI · Paper page
- Waterlow N.R., Cooper B.S., Robotham J.V. and Knight G.M.: Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS Med 2024; 21: e1004301. · DOI
- 10.1093/nar/gkt1099 · DOI · Paper page
- 10.12688/wellcomeopenres.14826.1 · DOI · Paper page
- Angers-Loustau A., Petrillo M., Bengtsson-Palme J., Berendonk T., Blais B., Chan K.-G., Coque T.M., Hammer P., Heß S. and Kagkli D.M.: The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies. F1000Research 2018; 7: 459. · doi:10.12688/f1000research.14509.2
- Tejeda M.I., Fernández J., Valledor P., Almirall C., Barberán J. and Romero-Brufau S.: Retrospective validation study of a machine learning-based software for empirical and organism-targeted antibiotic therapy selection. Antimicrob Agents Chemother 2024; 68: e0077724. · DOI
- Doyle R.M., O'sullivan D.M., Aller S.D., Bruchmann S., Clark T., Coello Pelegrin A., Cormican M., Diez Benavente E., Ellington M.J. and McGrath E.: Discordant bioinformatic predictions of antimicrobial resistance from whole-genome sequencing data of bacterial isolates: an inter-laboratory study. Microb Genom 2020; 6: e000335.
- Li Y., Cao Y., Wang M., Wang L., Wu Y., Fang Y., Zhao Y., Fan Y., Liu X. and Liang H.: Development and validation of machine learning models to predict MDRO colonization or infection on ICU admission by using electronic health record data. Antimicrob Resist Infect Control 2024; 13: 74. · DOI
- 10.1038/s41591-019-0503-6 · DOI · Paper page
- Fallach N., Dickstein Y., Silberschein E., Turnidge J., Temkin E., Almagor J., Carmeli Y. and Consortium D.-A.: Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level. Eurosurveillance 2020; 25: 1900387. · DOI
- 10.1038/s41467-019-08853-3 · DOI · Paper page
- MacIntyre C.R., Chen X., Kunasekaran M., Quigley A., Lim S., Stone H., Paik H.-y, Yao L., Heslop D. and Wei W.: Artificial intelligence in public health: the potential of epidemic early warning systems. J Int Med Res 2023; 51. 03000605231159335. · DOI
- Salim N.A.M., Wah Y.B., Reeves C., Smith M., Yaacob W.F.W., Mudin R.N., Dapari R., Sapri N.N.F.F. and Haque U.: Prediction of dengue outbreak in Selangor Malaysia using machine learning techniques. Sci Rep 2021; 11: 939. · doi:10.1038/s41598-020-79193-2
- Sundermann A.J., Chen J., Kumar P., Ayres A.M., Cho S.T., Ezeonwuka C., Griffith M.P., Miller J.K., Mustapha M.M., Pasculle A.W., Saul M.I., Shutt K.A., Srinivasa V., Waggle K., Snyder D.J., Cooper V.S., Van Tyne D., Snyder G.M., Marsh J.W., Dubrawski A., Roberts M.S. and Harrison L.H.: Whole-genome sequencing surveillance and machine learning of the electronic health record for enhanced healthcare outbreak detection. Clin Infect Dis 2022; 75: 476. · doi:10.1093/cid/ciab946
- Pascucci M., Royer G., Adamek J., Asmar M.A., Aristizabal D., Blanche L., Bezzarga A., Boniface-Chang G., Brunner A., Curel C., Dulac-Arnold G., Fakhri R.M., Malou N., Nordon C., Runge V., Samson F., Sebastian E., Soukieh D., Vert J.P., Ambroise C. and Madoui M.A.: AI-based mobile application to fight antibiotic resistance. Nat Commun 2021; 12: 1173. · DOI
- 10.1038/s41746-021-00442-3 · DOI
- 10.1089/mdr.2023.0232 · DOI
- 10.1038/s41576-023-00649-y · DOI · Paper page
- Wang Y., Jiang Z., Liang P., Liu Z., Cai H. and Sun Q.: TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations. BMC Genom 2024; 25: 167. · DOI
- Gao Y., Li H., Zhao C., Li S., Yin G. and Wang H.: Machine learning and feature extraction for rapid antimicrobial resistance prediction of Acinetobacter baumannii from whole-genome sequencing data. Front Microbiol 2024; 14: 1320312. · DOI
- Khaledi A., Weimann A., Schniederjans M., Asgari E., Kuo T.H., Oliver A., Cabot G., Kola A., Gastmeier P. and Hogardt M.: Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med 2020; 12: e10264. · DOI · Paper page
- 10.1021/acssynbio.4c00070 · DOI
- Zavišić G., Popović M., Stojkov S., Medić D., Gusman V., Jovanović Lješković N. and Jovanović Galović A.: Antibiotic resistance and probiotics: knowledge gaps, market overview and preliminary screening. Antibiotics 2023; 12: 1281. · DOI
- Worby C.J., Sridhar S., Turbett S.E., Becker M.V., Kogut L., Sanchez V., Bronson R.A., Rao S.R., Oliver E. and Walker A.T.: Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis. Lancet Microbe 2023; 4: e790. · DOI
- Rahman S.F., Olm M.R., Morowitz M.J. and Banfield J.F.: Machine learning leveraging genomes from metagenomes identifies influential antibiotic resistance genes in the infant gut microbiome. MSystems 2018; 3. 10.1128/msystems. 00123-00117. · DOI
- Madrigal P., Singh N.K., Wood J.M., Gaudioso E., Hernández-del-Olmo F., Mason C.E., Venkateswaran K. and Beheshti A.: Machine learning algorithm to characterize antimicrobial resistance associated with the International Space Station surface microbiome. Microbiome 2022; 10: 134. · DOI
- Willmann M., Vehreschild M.J., Biehl L.M., Vogel W., Dörfel D., Hamprecht A., Seifert H., Autenrieth I.B. and Peter S.: Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study. BMC Biol 2019; 17: 1. · DOI · Paper page
- Moradigaravand D., Senok A., Al-Dabal L., Khansaheb H.H., Habous M., Alsuwaidi H. and Alsheikh-Ali A.: Unveiling the dynamics of antimicrobial utilization and resistance in a large hospital network over five years: Insights from health record data analysis. PLOS Digit Health 2023; 2: e0000424. · DOI
- Struelens M.J., Ludden C., Werner G., Sintchenko V., Jokelainen P. and Ip M.: Real-time genomic surveillance for enhanced control of infectious diseases and antimicrobial resistance. Front Sci 2024; 2: 1298248. · DOI
- Agboeze T., Daramola O., Akomolafe A., Adedeji R. and Markwei J.: A predictive algorithm for the analysis of AMR trends and healthcare decision support. Wellcome Open Res 2024; 9: 274. · DOI
- 10.3201/eid2904.221552 · DOI
- Ali T., Ahmed S. and Aslam M.: Artificial intelligence for antimicrobial resistance prediction: challenges and opportunities towards practical implementation. Antibiotics 2023; 12: 523. · DOI · Paper page
- Yamin D., Uskoković V., Wakil A.M., Goni M.D., Shamsuddin S.H., Mustafa F.H., Alfouzan W.A., Alissa M., Alshengeti A., Almaghrabi R.H., Fares M.A.A., Garout M., Al Kaabi N.A., Alshehri A.A., Ali H.M., Rabaan A.A., Aldubisi F.A., Yean C.Y. and Yusof N.Y.: Current and future technologies for the detection of antibiotic-resistant bacteria. Diagnostics 2023; 13. · DOI · Paper page
- Khaledi A., Weimann A., Schniederjans M., Asgari E., Kuo T.H., Oliver A., Cabot G., Kola A., Gastmeier P., Hogardt M., Jonas D., Mofrad M.R., Bremges A., McHardy A.C. and Häussler S.: Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics. EMBO Mol Med 2020; 12: e10264. · DOI · Paper page
- Bilal H., Khan M.N., Rehman T., Hameed M.F. and Yang X.: Antibiotic resistance in Pakistan: a systematic review of past decade. BMC Infect Dis 2021; 21: 244. · DOI · Paper page
- Endale H., Mathewos M. and Abdeta D.: Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective-a review. Infect Drug Resist 2023; 16: 7515. · DOI · Paper page
- Li Y., Cui X., Yang X., Liu G. and Zhang J.: Artificial intelligence in predicting pathogenic microorganisms' antimicrobial resistance: challenges, progress, and prospects. Front Cell Infect Microbiol 2024; 14: 1482186. · DOI
- Ryu B., Jeon W. and Kim D.: Integrating genomic and molecular data to predict antimicrobial minimum inhibitory concentration in Klebsiella pneumoniae. Sci Rep 2024; 14: 25951. · DOI
- 10.3390/microorganisms12050842 · DOI
- Ren Y., Chakraborty T., Doijad S., Falgenhauer L., Falgenhauer J., Goesmann A., Hauschild A.-C., Schwengers O. and Heider D.: Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning. Bioinformatics 2021; 38: 325. · DOI · Paper page
- Tran Quoc V., Nguyen Thi Ngoc D., Nguyen Hoang T., Vu Thi H., Tong Duc M., Do Pham Nguyet T., Nguyen Van T., Ho Ngoc D., Vu Son G. and Bui Duc T.: Predicting antibiotic resistance in icus patients by applying machine learning in Vietnam. Infect Drug Resist 2023; 16: 5535. · DOI
- Vasala A., Hytönen V.P. and Laitinen O.H.: Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol 2020; 10: 308. · DOI · Paper page
- Fränti P. and Mariescu-Istodor R.: Soft precision and recall. Pattern Recognit Lett 2023; 167: 115. · DOI
- Kuang X., Wang F., Hernandez K.M., Zhang Z. and Grossman R.L.: Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN. Sci Rep 2022; 12: 2427. · DOI
- Nsubuga M., Galiwango R., Jjingo D. and Mboowa G.: Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa. BMC Genom 2024; 25: 287. · DOI
- Maleki Varnosfaderani S. and Forouzanfar M.: The Role of AI in Hospitals and Clinics: Transforming Healthcare in the 21st Century. Bioengeering 2024; 11: 337. · DOI · Paper page
- Harishbhai Tilala M., Kumar Chenchala P., Choppadandi A., Kaur J., Naguri S., Saoji R. and Devaguptapu B.: Ethical Considerations in the use of artificial intelligence and machine learning in health care: a comprehensive review. Cureus 2024; 16: e62443.
- Ho C.S., Wong C.T.H., Aung T.T., Lakshminarayanan R., Mehta J.S., Rauz S., McNally A., Kintses B., Peacock S.J., de la Fuente-Nunez C., Hancock R.E.W. and Ting D.S.J.: Antimicrobial resistance: a concise update. Lancet Microbe 2024; 0: 100947.
- Jones B.E., Ying J., Stevens V., Haroldsen C., He T., Nevers M., Christensen M.A., Nelson R.E., Stoddard G.J., Sauer B.C., Yarbrough P.M., Jones M.M., Goetz M.B., Greene T. and Samore M.H.: Empirical Anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern Med 2020; 180: 552. · DOI · Paper page
- Nigo M., Rasmy L., Mao B., Kannadath B.S., Xie Z. and Zhi D.: Deep learning model for personalized prediction of positive MRSA culture using time-series electronic health records. Nat Commun 2024; 15: 2036. · DOI
- Zhuang H., Zhu F., Lan P., Ji S., Sun L., Chen Y., Wang Z., Jiang S., Zhang L., Zhu Y., Jiang Y., Chen Y. and Yu Y.: A random forest model based on core genome allelic profiles of MRSA for penicillin plus potassium clavulanate susceptibility prediction. Micro Genom 2021; 7: 000610.
- Freire M.P., Rinaldi M., Terrabuio D.R.B., Furtado M., Pasquini Z., Bartoletti M., de Oliveira T.A., Nunes N.N., Lemos G.T., Maccaro A., Siniscalchi A., Laici C., Cescon M., Morelli L.A.C.D.A., Song M.C., Abdala A.T.W., Viale E., Filho P. and Giannella M A.: Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: a multicenter retrospective study. Transpl Infect Dis 2022; 24: e13920. · DOI
- Sakagianni A., Koufopoulou C., Koufopoulos P., Feretzakis G., Kalles D., Paxinou E., Myrianthefs P. and Verykios V.S.: The synergy of machine learning and epidemiology in addressing carbapenem resistance: a comprehensive review. Antibiotics 2024; 13: 996. · DOI
- Takekawa D., Endo H., Hashiba E. and Hirota K.: Predict models for prolonged ICU stay using APACHE II, APACHE III and SAPS II scores: a Japanese multicenter retrospective cohort study. PLoS One 2022; 17: e0269737. · DOI
- Jia H., Li X., Zhuang Y., Wu Y., Shi S., Sun Q., He F., Liang S., Wang J., Draz M.S., Xie X., Zhang J., Yang Q. and Ruan Z.: Neural network-based predictions of antimicrobial resistance phenotypes in multidrug-resistant Acinetobacter baumannii from whole genome sequencing and gene expression. Antimicrob Agents Chemother 2024; 68: e0144624. · DOI
- Boeing C., Correa-Martinez C.L., Schuler F., Mellmann A., Karch A. and Kampmeier S.: Development and Validation of a Tool for the Prediction of Vancomycin-Resistant Enterococci Colonization Persistence-the PREVENT Score. Microbiol Spectr 2021; 9: e0035621. · doi:10.1128/spectrum.00356-21
- van Niekerk J.M., Lokate M., Braakman-Jansen L.M.A., van Gemert-Pijnen J. and Stein A.: Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation. BMC Infect Dis 2022; 22: 67. · doi:10.1186/s12879-022-07043-9
- Sanyaolu A., Okorie C., Marinkovic A., Abbasi A.F., Prakash S., Mangat J., Hosein Z., Haider N. and Chan J.: Candida auris: an overview of the emerging drug-resistant fungal infection. Infect Chemother 2022; 54: 236. · DOI · Paper page
- Suphavilai C., Ko K.K.K., Lim K.M., Tan M.G., Boonsimma P., Chu J.J.K., Goh S.S., Rajandran P., Lee L.C., Tan K.Y., Shaik Ismail B.B., Aung M.K., Yang Y., Sim J.X.Y., Venkatachalam I., Cherng B.P.Z., Spruijtenburg B., Chan K.S., Oon L.L.E., Tan A.L., Tan Y.E., Wijaya L., Tan B.H., Ling M.L., Koh T.H., Meis J.F., Tsui C.K.M. and Nagarajan N.: Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe 2024; 5: 100878. · DOI · Paper page
- Shankarnarayan S.A., Ph D., Charlebois D.A. and Ph D.: Machine learning to identify clinically relevant Candida yeast species. Med Mycol 2023; 62. myad134.
- Cui Y., Yi C., Zhang C., Yang C., Wang X., Chen W., Peng Y. and Dai J.: Risk factors for bloodstream infection among patients admitted to an intensive care unit of a tertiary hospital of Shanghai, China. Sci Rep 2024; 14: 12765. · doi:10.1038/s41598-024-63594-8
- Werneburg G.T.: Catheter-Associated Urinary Tract Infections: current Challenges and Future Prospects. Res Rep Urol 2022; 14: 109.
- Ren J., Ning Z., Kirkness C.S., Asche C.V. and Wang H.: Risk of using logistic regression to illustrate exposure-response relationship of infectious diseases. BMC Infect Dis 2014; 14: 540. · DOI
- Taherpour N., Mehrabi Y., Seifi A. and Hashemi Nazari S.S.: A clinical prediction model for predicting the surgical site infection after an open reduction and internal fixation procedure considering the NHSN/SIR risk model: a multicenter case-control study. Front Surg 2023; 10: 1189220. · doi:10.3389/fsurg.2023.1189220
- Weaver M., Goodin D.A., Miller H.A., Karmali D., Agarwal A.A., Frieboes H.B. and Suliman S.A.: Prediction of prolonged mechanical ventilation in the intensive care unit via machine learning: a COVID-19 perspective. Sci Rep 2024; 14: 30173. · DOI
- Li L., Ayiguli A., Luan Q., Yang B., Subinuer Y., Gong H., Zulipikaer A., Xu J., Zhong X., Ren J. and Zou X.: Prediction and diagnosis of respiratory disease by combining convolutional neural network and Bi-directional long short-term memory methods. Front Public Health 2022; 10: 881234. · DOI
- Feucherolles M., Nennig M., Becker S.L., Martiny D., Losch S., Penny C., Cauchie H.M. and Ragimbeau C.: Combination of MALDI-TOF mass spectrometry and machine learning for rapid antimicrobial resistance screening: the case of campylobacter spp. Front Microbiol 2021; 12: 804484. · DOI
- Baker M., Zhang X., Maciel-Guerra A., Babaarslan K., Dong Y., Wang W., Hu Y., Renney D., Liu L., Li H., Hossain M., Heeb S., Tong Z., Pearcy N., Zhang M., Geng Y., Zhao L., Hao Z., Senin N., Chen J., Peng Z., Li F. and Dottorini T.: Convergence of resistance and evolutionary responses in Escherichia coli and Salmonella enterica co-inhabiting chicken farms in China. Nat Commun 2024; 15: 206. · DOI
- de la Lastra J.M.P., Wardell S.J.T., Pal T., de la Fuente-Nunez C. and Pletzer D.: From data to decisions: leveraging artificial intelligence and machine learning in combating antimicrobial resistance - a comprehensive review. J Med Syst 2024; 48: 71. · DOI
- Lim C., Miliya T., Chansamouth V., Aung M.T., Karkey A., Teparrukkul P., Rahul B., Lan N.P.H., Stelling J., Turner P., Ashley E., van Doorn H.R., Lin H.N., Ling C., Hinjoy S., Iamsirithaworn S., Dunachie S., Wangrangsimakul T., Hantrakun V., Schilling W., Yen L.M., Tan L.V., Hlaing H.H., Mayxay M., Vongsouvath M., Basnyat B., Edgeworth J., Peacock S.J., Thwaites G., Day N.P., Cooper B.S. and Limmathurotsakul D.: Automating the generation of antimicrobial resistance surveillance reports: proof-of-concept study involving seven hospitals in seven countries. J Med Internet Res 2020; 22: e19762. · doi:10.2196/19762
- Khan N., Nauman M., Almadhor A.S., Akhtar N., Alghuried A. and Alhudhaif A.: Guaranteeing correctness in black-box machine learning: a fusion of explainable ai and formal methods for healthcare decision-making. IEEE Access 2024; 12: 90299. · DOI
- Habib A.R. and Gross C.P.: FDA Regulations of AI-driven clinical decision support devices fall short. JAMA Intern Med 2023; 183: 1401. · DOI
- 10.1016/j.future.2022.02.021 · DOI
- Xu J., Li F., Leier A., Xiang D., Shen H.H., Marquez Lago T.T., Li J., Yu D.J. and Song J.: Comprehensive assessment of machine learning-based methods for predicting antimicrobial peptides. Brief Bioinform 2021; 22: bbab083. · DOI
- Yang M.-R. and Wu Y.-W.: Enhancing predictions of antimicrobial resistance of pathogens by expanding the potential resistance gene repertoire using a pan-genome-based feature selection approach. BMC Bioinforma 2022; 23: 131. · DOI
- Arango-Argoty G., Garner E., Pruden A., Heath L.S., Vikesland P. and Zhang L.: DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data. Microbiome 2018; 6: 23. · DOI · Paper page
- Aytan-Aktug D., Clausen P.T.L.C., Bortolaia V., Aarestrup F.M. and Lund O.: Prediction of acquired antimicrobial resistance for multiple bacterial species using neural networks. Msystems 2020; 5. e00774-00719. · DOI
- Aledo J.A., Andreu-Vilarroig C., Cortés J.-C., Orengo J.C. and Villanueva R.-J.: A random mathematical model to describe the antibiotic resistance depending on the antibiotic consumption: the Acinetobacter baumannii colistin-resistant case in Valencia, Spain. Int J Comput Math 2024; 102: 74. · DOI
- Sturm A., Jóźwiak G., Verge M.P., Munch L., Cathomen G., Vocat A., Luraschi-Eggemann A., Orlando C., Fromm K. and Delarze E.: Accurate and rapid antibiotic susceptibility testing using a machine learning-assisted nanomotion technology platform. Nat Commun 2024; 15: 2037. · DOI
- Zhang M., Wang C. and O’Connor A.: A Bayesian approach to modeling antimicrobial multidrug resistance. Plos One 2021; 16: e0261528. · doi:10.1371/journal.pone.0261528
- Tran Quoc V., Nguyen Thi Ngoc D., Nguyen Hoang T., Vu Thi H., Tong Duc M., Do Pham Nguyet T., Nguyen Van T., Ho Ngoc D., Vu Son G. and Bui Duc T.: Predicting antibiotic resistance in ICUs patients by applying machine learning in Vietnam. Infect Drug Resist 2023; 16: 5535. · DOI
- Marciano S., Piano S., Singh V., Caraceni P., Maiwall R., Alessandria C., Fernandez J., Kim D.J., Kim S.E., Soares E., Marino M., Vorobioff J., Merli M., Elkrief L., Vargas V., Krag A., Singh S., Elizondo M., Anders M.M., Dirchwolf M., Mendizabal M., Lesmana C.R.A., Toledo C., Wong F., Durand F., Gadano A., Giunta D.H. and Angeli P.: Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis. Liver Int 2024; 44: 2915. · DOI
- Shi J., Yan Y., Links M.G., Li L., Dillon J.-A.R., Horsch M. and Kusalik A.: Antimicrobial resistance genetic factor identification from whole-genome sequence data using deep feature selection. BMC Bioinforma 2019; 20: 535. · DOI
- Chowdhury A.S., Call D.R. and Broschat S.L.: Antimicrobial resistance prediction for gram-negative bacteria via game theory-based feature evaluation. Sci Rep 2019; 9: 14487. · DOI
- Tian Y., Zhang D., Chen F., Rao G. and Zhang Y.: Machine learning-based colistin resistance marker screening and phenotype prediction in Escherichia coli from whole genome sequencing data. J Infect 2024; 88: 191. · doi:10.1016/j.jinf.2023.11.009
- Pesesky M.W., Hussain T., Wallace M., Patel S., Andleeb S., Burnham C.-A.D. and Dantas G.: Evaluation of machine learning and rules-based approaches for predicting antimicrobial resistance profiles in gram-negative bacilli from whole genome sequence data. Front Microbiol 2016; 7: 1887. · DOI
- Dang J., Shu J., Wang R., Yu H., Chen Z., Yan W., Zhao B., Ding L., Wang Y., Hu H. and Li Z.: The glycopatterns of Pseudomonas aeruginosa as a potential biomarker for its carbapenem resistance. Microbiol Spectr 2023; 11: e02001. · DOI
- Stanton R.A., Campbell D., McAllister G.A., Breaker E., Adamczyk M., Daniels J.B., Lutgring J.D., Karlsson M., Schutz K., Jacob J.T., Wilson L.E., Vaeth E., Li L., Lynfield R., Vagnone P.M.S., Phipps E.C., Hancock E.B., Dumyati G., Tsay R., Cassidy P.M., Mounsey J., Grass J.E., Bulens S.N., Walters M.S. and Halpin A.L.: Whole-genome sequencing reveals diversity of carbapenem-resistant pseudomonas aeruginosa collected through CDC's emerging infections program, United States, 2016-2018. Antimicrob Agents Chemother 2022; 66. e00496-00422. · DOI
- Lu J., Chen J., Liu C., Zeng Y., Sun Q., Li J., Shen Z., Chen S. and Zhang R.: Identification of antibiotic resistance and virulence-encoding factors in Klebsiella pneumoniae by Raman spectroscopy and deep learning. Micro Biotechnol 2022; 15: 1270. · DOI
- Portelli S., Myung Y., Furnham N., Vedithi S.C., Pires D.E.V. and Ascher D.B.: Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches. Sci Rep 2020; 10: 18120. · DOI
- Yasir M., Karim A.M., Malik S.K., Bajaffer A.A. and Azhar E.I.: Application of decision-tree-based machine learning algorithms for prediction of antimicrobial resistance. Antibiotics 2022; 11: 1593. · DOI
- Pataki B.Á., Matamoros S., van der Putten B.C.L., Remondini D., Giampieri E., Aytan-Aktug D., Hendriksen R.S., Lund O., Csabai I., Schultsz C., Matamoros S., Janes V., Hendriksen R.S., Lund O., Clausen P., Aarestrup F.M., Koopmans M., Pataki B., Visontai D., Stéger J., Szalai-Gindl J.M., Csabai I., Pakseresht N., Rossello M., Silvester N., Amid C., Cochrane G., Schultsz C., Pradel F., Westeel E., Fuchs S., Kumar S.M., Xavier B.B., Ngoc M.N., Remondini D., Giampieri E., Pasquali F., Petrovska L., Ajayi D., Nielsen E.M., Trung N.V., Hoa N.T., Ishii Y., Aoki K., McDermott P. and group S.C.M.-A.: Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning. Sci Rep 2020; 10: 15026. · DOI
- 10.1371/journal.pcbi.1007608 · DOI
- Yan J., Zhang B., Zhou M., Campbell-Valois F.-X. and Siu S.W.I.: A deep learning method for predicting the minimum inhibitory concentration of antimicrobial peptides against Escherichia coli using Multi-Branch-CNN and Attention. mSystems 8(4):e00345-00323 2023; .
- 10.3390/biology9110365 · DOI
- 10.1016/j.csbj.2022.03.007 · DOI
- Ayoola M.B., Das A.R., Krishnan B.S., Smith D.R., Nanduri B. and Ramkumar M.: Predicting Salmonella MIC and deciphering genomic determinants of antibiotic resistance and susceptibility. Microorganisms 2024; 12: 134. · DOI
- Jeon K., Kim J.-M., Rho K., Jung S.H., Park H.S. and Kim J.-S.: Performance of a Machine learning-based methicillin resistance of staphylococcus aureus identification system using MALDI-TOF MS and comparison of the accuracy according to sccmec types. Microorganisms 2022; 10: 1903. · DOI
- Wang S., Zhao C., Yin Y., Chen F., Chen H. and Wang H.: A practical approach for predicting antimicrobial phenotype resistance in staphylococcus aureus through machine learning analysis of genome data. Front Microbiol 2022; 13: 841289. · DOI
- Udegbe F.C., Ebulue O.R., Ebulue C.C. and Ekesiobi C.S.: Machine learning in drug discovery: a critical review of applications and challenges. Comput Sci IT Res J 2024; 5: 892. · DOI
- 10.1038/s41592-023-02087-4 · DOI · Paper page
- Schuhmacher A., Haefner N., Honsberg K., Goldhahn J. and Gassmann O.: The dominant logic of Big Tech in healthcare and pharma. Drug Discov Today 2023; 28: 103457. · DOI
- Bess A., Berglind F., Mukhopadhyay S., Brylinski M., Griggs N., Cho T., Galliano C. and Wasan K.M.: Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases. Drug Discov Today 2022; 27: 1099. · DOI
- 10.1038/nchembio.1884 · DOI · Paper page
- 10.1038/s41576-021-00363-7 · DOI · Paper page
- 10.1038/s41573-023-00774-7 · DOI · Paper page
- 10.1038/s41587-021-01045-9 · DOI · Paper page
- 10.1016/j.jhazmat.2018.09.047 · DOI · Paper page
- Zheng S., Zeng T., Li C., Chen B., Coley C.W., Yang Y. and Wu R.: Deep learning driven biosynthetic pathways navigation for natural products with BioNavi-NP. Nat Commun 2022; 13: 3342. · DOI · Paper page
- Reher R., Kim H.W., Zhang C., Mao H.H., Wang M., Nothias L.F., Caraballo-Rodriguez A.M., Glukhov E., Teke B., Leao T., Alexander K.L., Duggan B.M., Van Everbroeck E.L., Dorrestein P.C., Cottrell G.W. and Gerwick W.H.: A Convolutional Neural Network-Based Approach for the Rapid Annotation of Molecularly Diverse Natural Products. J Am Chem Soc 2020; 142: 4114. · DOI · Paper page
- 10.1093/nar/gkz654 · DOI · Paper page
- Melo M.C., Maasch J.R. and de la Fuente-Nunez C.: Accelerating antibiotic discovery through artificial intelligence. Commun Biol 2021; 4: 1050. · DOI · Paper page
- 10.1039/D1SC04471K · DOI · Paper page
- Jana T., Sarkar D., Ganguli D., Mukherjee S.K., Mandal R.S. and Das S.: ABDpred: Prediction of active antimicrobial compounds using supervised machine learning techniques. Indian J Med Res 2024; 159: 78. · DOI
- 10.1016/j.cell.2024.05.013 · DOI · Paper page
- 10.1038/s41586-023-06887-8 · DOI · Paper page
- Lin T.-T., Yang L.-Y., Lin C.-Y., Wang C.-T., Lai C.-W., Ko C.-F., Shih Y.-H. and Chen S.-H.: Intelligent de novo design of novel antimicrobial peptides against antibiotic-resistant bacteria strains. Int J Mol Sci 2023; 24: 6788. · DOI
- Zhang Y., Zhao C., Wang Q., Wang X., Chen H., Li H., Zhang F. and Wang H.: Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli. J Antimicrob Chemother 2020; 75: 2609. · DOI
- Castanheira M., Lindley J., Huynh H., Mendes R.E. and Lomovskaya O.: 690. Activity of a Novel Polymyxin Analog, QPX9003, Tested against resistant gram-negative pathogens, including carbapenem-resistant acinetobacter, enterobacterales, and pseudomonas. Open Forum Infect Dis 2019; 6. S313–S313. · doi:10.1093/ofid/ofz360.758
- Duncan L.R., Wang W. and Sader H.S.: In vitro potency and spectrum of the novel polymyxin mrx-8 tested against clinical isolates of gram-negative bacteria. Antimicrob Agents Chemother 2022; 66: e0013922. · doi:10.1128/aac.00139-22
- Sader H.S., Dale G.E., Rhomberg P.R. and Flamm R.K.: Antimicrobial activity of murepavadin tested against clinical isolates of pseudomonas aeruginosa from the United States, Europe, and China. Antimicrob Agents Chemother 2018; 62: e00311. · DOI
- 10.1128/AAC.44.7.1803-1808.2000 · DOI
- 10.1016/j.cell.2020.05.005 · DOI · Paper page
- 10.1128/AAC.43.5.1274 · DOI
- Wu X., Wang Z., Li X., Fan Y., He G., Wan Y., Yu C., Tang J., Li M., Zhang X., Zhang H., Xiang R., Pan Y., Liu Y., Lu L. and Yang L.: In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method. Antimicrob Agents Chemother 2014; 58: 5342. · DOI
- 10.1016/j.chom.2023.07.001 · DOI
- 10.1016/j.chempr.2018.01.005 · DOI · Paper page
- Cao Q., Ge C., Wang X., Harvey P.J., Zhang Z., Ma Y., Wang X., Jia X., Mobli M., Craik D.J., Jiang T., Yang J., Wei Z., Wang Y., Chang S. and Yu R.: Designing antimicrobial peptides using deep learning and molecular dynamic simulations. Brief Bioinforma 2023; 24: bbad058. · DOI
- 10.1074/jbc.M117.805499 · DOI
- 10.1038/s41551-022-00991-2 · DOI · Paper page
- 10.1038/s41467-018-03746-3 · DOI · Paper page
- 10.1038/s41587-022-01226-0 · DOI · Paper page
- 10.1021/acsomega.0c00442 · DOI
- 10.3389/fmicb.2021.725727 · DOI · Paper page
- 10.1021/acsomega.0c02088 · DOI
- 10.1039/D1SC01713F · DOI · Paper page
- Kulkarni V., Alagarsamy V., Solomon V., Jose P. and Murugesan S.: Drug repurposing: an effective tool in modern drug discovery. Russ J Bioorg Chem 2023; 49: 157. · DOI · Paper page
- Awan R.E., Zainab S., Yousuf F.J. and Mughal S.: AI-driven drug discovery: Exploring Abaucin as a promising treatment against multidrug-resistant Acinetobacter baumannii. Health Sci Rep 2024; 7: e2150. · DOI
- Abdulla A., Wang B., Qian F., Kee T., Blasiak A., Ong Y.H., Hooi L., Parekh F., Soriano R. and Olinger G.G.: Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention. Adv Ther 2020; 3: 2000034. · DOI
- Li M., You K., Wang P., Hooi L., Chen Y., Siah A., Tan S.B., Teo J., Ng O.T. and Marimuthu K.: Discovery of broad-spectrum repurposed drug combinations against carbapenem-resistant enterobacteriaceae (cre) through artificial intelligence (ai)-driven platform. Adv Ther 2024; 7: 2300332. · DOI
- Abouzahra M., Guenter D. and Tan J.: Exploring physicians’ continuous use of clinical decision support systems. Eur J Inf Syst 2024; 33: 123. · DOI
- Khalifa M., Albadawy M. and Iqbal U.: Advancing clinical decision support: the role of artificial intelligence across six domains. Comput Methods Prog Biomed Update 2024; 13: 100142. · DOI
- Huang Z., George M.M., Tan Y.-R., Natarajan K., Devasagayam E., Tay E., Manesh A., Varghese G.M., Abraham O.C. and Zachariah A.: Are physicians ready for precision antibiotic prescribing? A qualitative analysis of the acceptance of artificial intelligence-enabled clinical decision support systems in India and Singapore. J Glob Antimicrob Resist 2023; 35: 76. · DOI
- Gupta Y.D. and Bhandary S.: Artificial intelligence for understanding mechanisms of antimicrobial resistance and antimicrobial discovery: a new age model for translational research. Artif Intell Mach Learn Drug Des Dev 2024; : 117. https://doi.org/110.1002/9781394234196.ch9781394234195. · doi:10.1002/9781394234196.ch9781394234195
- Liu G.-Y., Yu D., Fan M.-M., Zhang X., Jin Z.-Y., Tang C. and Liu X.-F.: Antimicrobial resistance crisis: could artificial intelligence be the solution?. Mil Med Res 2024; 11: 7.
- Tokgöz P., Krayter S., Hafner J. and Dockweiler C.: Decision support systems for antibiotic prescription in hospitals: a survey with hospital managers on factors for implementation. BMC Med Inform Decis Mak 2024; 24: 96. · DOI
- Herter W.E., Khuc J., Cinà G., Knottnerus B.J., Numans M.E., Wiewel M.A., Bonten T.N., de Bruin D.P., van Esch T. and Chavannes N.H.: Impact of a Machine Learning–based decision support system for urinary tract infections: prospective observational study in 36 primary care practices. JMIR Med Inform 2022; 10: e27795. · DOI
- Khorram-Manesh A., Burkle Jr F.M. and Goniewicz K.: Pandemics: past, present, and future: multitasking challenges in need of cross-disciplinary, transdisciplinary, and multidisciplinary collaborative solutions. Osong Public Health Res Perspect 2024; 15: 267. · DOI
- Branda F.: The impact of artificial intelligence in the fight against antimicrobial resistance. Infect Dis 2024; 56: 484. · doi:10.1080/23744235.2024.2331255
- Theodosiou A.A. and Read R.C.: Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician. J Infect 2023; 87: 287. · DOI · Paper page
- 10.3390/microorganisms12050842 · DOI
- Kim J.I., Maguire F., Tsang K.K., Gouliouris T., Peacock S.J., McAllister T.A., McArthur A.G. and Beiko R.G.: Machine learning for antimicrobial resistance prediction: current practice, limitations, and clinical perspective. Clin Microbiol Rev 2022; 35. e00179-00121.
- Vashisht V., Vashisht A., Mondal A.K., Farmaha J., Alptekin A., Singh H., Ahluwalia P., Srinivas A. and Kolhe R.: Genomics for emerging pathogen identification and monitoring: prospects and obstacles. BioMedInformatics 2023; 3: 32. · DOI
- Worth R.M. and Espina L.: ScanGrow: deep learning-based live tracking of bacterial growth in broth. Front Microbiol 2022; 13: 900596. · doi:10.3389/fmicb.2022.900596
Cited by
Understanding the Functionality of Probiotics on the Edge of Artificial Intelligence (AI) Era
Asar, R., Erenler, S., Devecioglu, D., Ispirli, H., Karbancioglu-Guler, F., Ozturk, H. I., & Dertli, E. (2025) · Fermentation · doi:10.3390/fermentation11050259 · Cited by 37
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Bilal, H., Khan, M. N., Khan, S., Shafiq, M., Fang, W., Khan, R. U., Rahman, M. U., Li, X., Lv, Q.-L., & Xu, B.
- Affiliations
- Jiangxi Key Laboratory of oncology (2024SSY06041), JXHC Key Laboratory of Tumour Metastasis, NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi 330029, PR China
- Department of Cell Biology and Genetics, Shantou University Medical College, Shantou 515041, China
- Department of Dermatology, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, China
- Research Institute of Clinical Pharmacy, Department of Pharmacology, Shantou University Medical College, Shantou 515041, China
- Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 101408, China
- Biofuels Institute, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, China
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2025-01-01
- Volume
- 27
- Pages
- 423-439
- ISSN
- 2001-0370
- Cited by
- 120
- References
- 14
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 12 d)
- Funders
- Jiangsu Cancer Hospital (BSQDJ2024001)
- Natural Science Foundation of Jiangxi Province (2021DYS01, 20224ACB216015)
- Health Commission of Jiangxi Province
- Education Department of Jiangxi Province (GJJ2403604, GJJ2203508)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance. https://app.cochat.ai/papers/10.1016/j.csbj.2025.01.006
- The paper
- Bilal, H., Khan, M. N., Khan, S., Shafiq, M., Fang, W., Khan, R. U., Rahman, M. U., Li, X., Lv, Q.-L., & Xu, B. (2025). The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance. Computational and Structural Biotechnology Journal. https://doi.org/10.1016/j.csbj.2025.01.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.